Royal Philips Electronics (NYSE: PHG, AEX: PHI) announced the availability of CardioCare Wireless Arrhythmia Services, the latest addition to the company’s remote diagnostic arrhythmia and remote patient monitoring portfolio. This new service, available only in the U.S., is designed to streamline the complex process of remotely monitoring cardiac patients and capture critical information sooner.
With Philips CardioCare, patients wear a one-piece monitor with an intuitive interface designed to help improve compliance. Using this device, patients’ heartbeats are transmitted wirelessly to highly qualified cardiac technicians at the Philips Clinical Evaluation Center, who can analyze them and alert cardiologists to critical patient data. This capability is an evolution beyond previous monitors, which transmitted patient data over telephone lines. As part of its portfolio of services, Philips distributes the wireless monitor made by TZ Medical, which is backed by industry-leading technology. The monitor received FDA marketing clearance last year.
Philips’ helps cardiologists remotely monitor patients for a range of arrhythmias and gives them the ability to select the appropriate type of monitoring for each patient. For symptomatic patients, CardioCare is designed to help them link their symptoms to their activity level. For patients who do not experience symptoms, CardioCare can automatically recognize and record cardiac events. In either mode, the monitor will transmit recorded events wirelessly back to the Philips call center without patient interaction.
For more information, visit www.philips.com/newscenter.